{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:22:14Z","timestamp":1787595734783,"version":"build-2736575974"},"reference-count":52,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,10,10]],"date-time":"2009-10-10T00:00:00Z","timestamp":1255132800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2010,1]]},"abstract":"<jats:p>We describe novel humanized anti\u2010CD20 monoclonal antibodies (mAbs) developed for therapeutic use on the basis of their physicochemical properties and cellular cytotoxicity. A distinct correlation between apparent dissociation constants (<jats:italic>K<\/jats:italic><jats:sub>d<\/jats:sub>) and apoptotic activity for eight murine anti\u2010CD20 mAbs (OUBM1\u2013OUBM8) and previously\u2010developed murine anti\u2010CD20 mAbs enabled us to categorize anti\u2010CD20 mAbs into two groups. Group A mAbs had lower <jats:italic>K<\/jats:italic><jats:sub>d<\/jats:sub> values and did not induce definite apoptosis, while Group B mAbs had greater <jats:italic>K<\/jats:italic><jats:sub>d<\/jats:sub> values and did induce definite apoptosis. A murine version mAb of rituximab, 2B8, belongs to Group B. An epitope analysis showed that the epitope of two murine mAbs, OUBM3 and OUBM6, differed from that of 2B8 or 2F2 (ofatumumab). Two mAbs, OUBM3 from Group A and OUBM6 from Group B, were selected and humanized. As expected, the humanized OUBM3 with the lower <jats:italic>K<\/jats:italic><jats:sub>d<\/jats:sub> did not induce apoptosis, while the humanized OUBM6 (hOUBM6) with the greater <jats:italic>K<\/jats:italic><jats:sub>d<\/jats:sub> did. Both hOUBM3 and hOUBM6 induced highly\u2010effective, complement\u2010dependent cytotoxicity and antibody\u2010dependent, cell\u2010mediated cytotoxicity against Burkitt\u2019s and follicular lymphomas. Importantly, hOUBM6 exhibited cellular cytotoxicity against diffuse, large B cells that are less effectively depleted by rituximab and also exhibited effective cytotoxicity against tumor cells from human CD20(+) leukemia and lymphoma patients. These results suggest the potential impact of the further development of our anti\u2010CD20 mAbs. Our study shows that the selection of mAbs based on their physicochemical parameters, followed by the biological activity assessment for the selected mAbs, is a rational and efficient approach for pharmaceutical mAb development. (<jats:italic>Cancer Sci<\/jats:italic> 2009)<\/jats:p>","DOI":"10.1111\/j.1349-7006.2009.01392.x","type":"journal-article","created":{"date-parts":[[2009,10,10]],"date-time":"2009-10-10T14:56:22Z","timestamp":1255186582000},"page":"201-209","source":"Crossref","is-referenced-by-count":42,"title":["Development of novel humanized anti\u2010CD20 antibodies based on affinity constant and epitope"],"prefix":"10.1111","volume":"101","author":[{"given":"Susumu","family":"Uchiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Otake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuo","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midori","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuji","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitoyo","family":"Kagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiichi","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,12,9]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(94)90276-3"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.121.5.1121"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M308802200"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2002.01495.x"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.4049\/jimmunol.151.9.4494","article-title":"Association of tyrosine and serine kinases with the B cell surface antigen CD20. Induction via CD20 of tyrosine phosphorylation and activation of phospholipase C\u2010\u03b31 and PLC phospholipase C\u2010\u03b32","volume":"151","author":"Deans JP","year":"1993","journal-title":"J Immunol"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2126(94)90092-2"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.8.2457.2457"},{"key":"e_1_2_6_9_2","first-page":"63","article-title":"Newer treatments for non\u2010Hodgkin\u2019s lymphoma: monoclonal antibodies","volume":"10","author":"Maloney DG","year":"1998","journal-title":"Oncology"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.5.1644"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-001-0247-1"},{"key":"e_1_2_6_12_2","first-page":"7170","article-title":"Anti\u2010CD20\u2010 and B\u2010cell receptor\u2010mediated apoptosis: evidence for shared intracellular signaling pathways","volume":"60","author":"Mathas S","year":"2002","journal-title":"Cancer Res"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.1998.tb03280.x"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1006\/bcmd.2000.0287"},{"key":"e_1_2_6_15_2","first-page":"5480","article-title":"CD20\u2010induced lymphoma cell death is independent of both caspases and its redistribution into triton X\u2010100 insoluble membrane rafts","volume":"63","author":"Chan HT","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_6_16_2","first-page":"5137","article-title":"Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B\u2010non\u2010Hodgkin\u2019s lymphoma through inhibition of the interleukin 10 autocrine\/paracrine loop and results in down\u2010regulation of Bcl\u20102 and sensitization to cytotoxic drugs","volume":"61","author":"Alas S","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.2.435.435"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-02-0469"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/74704"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.3.754"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.4.2600"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1042\/bst0250705"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2007.06.151"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.8.2825"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.1.268"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011795"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.05.013"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-0745"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1403"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-08-175208"},{"key":"e_1_2_6_31_2","first-page":"29","article-title":"Characterization of novel murine anti\u2010CD20 monoclonal antibodies and their comparison to 2B8 and c2B8 (rituximab)","volume":"31","author":"Nishida M","year":"2007","journal-title":"Int J Oncol"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.3892\/ijo_32_6_1263"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-11-126243"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.9.3256"},{"key":"e_1_2_6_35_2","first-page":"6708","article-title":"Rearrangements on chromosome 11q23 in hematopoietic tumor\u2010associated t(11;14) and t(11;19) translocations","volume":"51","author":"Akao Y","year":"1991","journal-title":"Cancer Res"},{"key":"e_1_2_6_36_2","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.4049\/jimmunol.134.5.3056","article-title":"Therapeutic potential of rat monoclonal antibodies: isotype specificity of antibody\u2010dependent cell\u2010mediated cytotoxicity with human lymphocytes","volume":"134","author":"Hale G","year":"1985","journal-title":"J Immunol"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210448"},{"key":"e_1_2_6_38_2","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2009-03-212191","article-title":"Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival","volume":"114","author":"Johnson NA","year":"2009","journal-title":"Blood"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1254"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1255"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0039"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.1.362"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1761"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M400525200"},{"key":"e_1_2_6_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830181006"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.12.3383"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.12.3900"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2006.00139.x"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.5.1352"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1336"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.2.1129"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2005.08.009"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0508123103"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2009.01392.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2009.01392.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T16:23:04Z","timestamp":1698769384000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2009.01392.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,9]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["10.1111\/j.1349-7006.2009.01392.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2009.01392.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,9]]}}}